Ms Adiletto will be responsible for the management of all clinical and regulatory activities, as well as further development of the company’s regulatory strategy.
Prior to joining BG Medicine, Ms Adiletto served as senior vice president of clinical operations and regulatory affairs at WorldCare Clinical and vice president of clinical and regulatory at Inverness Medical Innovations.
Pieter Muntendam, president and CEO of BG Medicine, said: “During her years as director and vice president of clinical and regulatory at Inverness Medical, Carol played an important role in establishing Inverness as one of the leading in vitro diagnostic companies. This wealth of experience will enable Carol to lead the clinical and regulatory activities for our innovative diagnostics in cardiology and other therapeutic areas.”